| Influenza A 2009 H1N1 Challenge Study in Healthy Adults (NCT01646138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine (NCT01545349) | Patricia L. Hibberd | 2012-02-01 |
| Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone (NCT01498718) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Maternal Immunization: Giving Immunity For Tomorrow (NCT01496079) | University of Utah | 2011-12-01 |
| Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS) (NCT01456234) | Trial Management Group Inc. | 2011-11-01 |
| A Study of Exclusion Criteria in a University Population (NCT01472536) | University of Michigan | 2011-11-01 |
| Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs) (NCT01424371) | Fraser Health | 2011-11-01 |
| The Safety and Immune Response to Influenza Vaccination in Pregnant Women (NCT01514708) | Adimmune Corporation | 2011-11-01 |
| Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand (NCT01538940) | Centers for Disease Control and Prevention | 2011-11-01 |
| Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting (NCT01654224) | University of Pittsburgh | 2011-11-01 |
| Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults (NCT01517191) | Dalhousie University | 2011-11-01 |
| Optimizing Influenza Vaccination in Surgical Oncology Patients (NCT01698177) | Stony Brook University | 2011-10-01 |
| A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects (NCT01459276) | Fluart Innovative Vaccine Ltd, Hungary | 2011-10-01 |
| A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine (NCT01465035) | University of Oxford | 2011-10-01 |
| An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children (NCT01439360) | GlaxoSmithKline | 2011-10-01 |
| The Effect of Proximity on Flu-Shot Participation (NCT01455753) | National Bureau of Economic Research, Inc. | 2011-10-01 |
| Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients (NCT01512056) | National Cheng-Kung University Hospital | 2011-10-01 |
| Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers (NCT01412281) | Crucell Holland BV | 2011-10-01 |
| A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season (NCT01457027) | Crucell Holland BV | 2011-10-01 |
| TIV and High Dose TIV in Subjects With Rheumatoid Arthritis (NCT01436370) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-01 |
| A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older (NCT01440387) | GlaxoSmithKline | 2011-09-30 |
| Maternal Flu Vaccine Trial in Bamako, Mali (NCT01430689) | University of Maryland, Baltimore | 2011-09-12 |
| A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold (NCT01651663) | Pharmstandard | 2011-09-01 |
| Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults (NCT01430819) | Sanofi Pasteur, a Sanofi Company | 2011-09-01 |
| Influenza Burden Assessment in the United Kingdom, 1996-2008 (NCT01520935) | GlaxoSmithKline | 2011-09-01 |
| Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects (NCT01422512) | Novartis Vaccines | 2011-09-01 |
| Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women (NCT01181323) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People (NCT01408290) | Fluart Innovative Vaccine Ltd, Hungary | 2011-09-01 |
| T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011 (NCT03022422) | Stanford University | 2011-09-01 |
| A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults (NCT01427309) | Sanofi Pasteur, a Sanofi Company | 2011-09-01 |
| Influenza Antiviral DAS-181-F04 in Healthy Adults (NCT01651494) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-12 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults (NCT01416571) | GlaxoSmithKline | 2011-08-12 |
| Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects (NCT01313962) | Autoimmune Technologies, LLC | 2011-08-01 |
| A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains (NCT01416597) | GlaxoSmithKline | 2011-08-01 |
| A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers (NCT01419925) | BiondVax Pharmaceuticals ltd. | 2011-08-01 |
| Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) (NCT02141581) | Stanford University | 2011-08-01 |
| Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects (NCT01411358) | Adimmune Corporation | 2011-08-01 |
| A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children (NCT01379937) | GlaxoSmithKline | 2011-07-28 |
| Screening for LID Clinical Studies Unit Healthy Volunteer Protocols (NCT01386424) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-20 |
| Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B (NCT01431768) | Respirio Pty Ltd | 2011-07-01 |
| Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons (NCT01404182) | Fluart Innovative Vaccine Ltd, Hungary | 2011-07-01 |
| Safety Study of Single Administration Intravenous Treatment for Influenza (NCT01375985) | Sarepta Therapeutics, Inc. | 2011-06-01 |
| Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects (NCT01342796) | Novartis Vaccines | 2011-05-01 |
| Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers (NCT01444482) | Isconova AB | 2011-05-01 |
| A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies (NCT01332578) | GlaxoSmithKline | 2011-05-01 |
| H5N1 Mix and Match With AS03 (NCT01317758) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| H5N1 Mix and Match With MF59 (NCT01317745) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children (NCT01323946) | GlaxoSmithKline | 2011-04-18 |
| Testing the Use of Prompts to Increase Adolescent Immunization Rates (NCT01984125) | University of California, Los Angeles | 2011-04-01 |
| Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age (NCT01310413) | GlaxoSmithKline | 2011-03-07 |
| Influenza Vaccine Trial in HIV Uninfected Pregnant Women (NCT01306669) | University of Witwatersrand, South Africa | 2011-03-03 |
| Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity (NCT01306682) | University of Witwatersrand, South Africa | 2011-03-01 |
| Reverse Genetic H9N2 Influenza Vaccine Study in Adults (NCT01320696) | Alachua Government Services, Inc. | 2011-03-01 |
| Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years (NCT03101462) | St. Louis University | 2011-02-24 |
| Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza (NCT01804946) | Materia Medica Holding | 2011-02-01 |
| "Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study" (NCT01309568) | Quidel Corporation | 2011-02-01 |
| Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections (NCT02665351) | Chinese University of Hong Kong | 2011-02-01 |
| Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection (NCT02597647) | University of California, Los Angeles | 2011-02-01 |
| A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza (NCT01053663) | Hoffmann-La Roche | 2011-01-01 |
| Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure (NCT01045564) | GlaxoSmithKline | 2011-01-01 |
| A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection (NCT00988325) | Hoffmann-La Roche | 2011-01-01 |
| A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children (NCT01218308) | GlaxoSmithKline | 2010-12-09 |
| Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly (NCT01304771) | Mayo Clinic | 2010-12-01 |
| A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza (NCT01033734) | Hoffmann-La Roche | 2010-12-01 |
| Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza (NCT01227421) | Romark Laboratories L.C. | 2010-12-01 |
| Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S. (NCT01262079) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-01 |
| The Respiratory Protection Effectiveness Clinical Trial (NCT01249625) | Johns Hopkins University | 2010-12-01 |
| Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old (NCT01236040) | GlaxoSmithKline | 2010-11-29 |
| Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain (NCT01592799) | GlaxoSmithKline | 2010-11-23 |
| Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine (NCT01224613) | Dalhousie University | 2010-11-01 |
| Study of Quadrivalent Influenza Vaccine Among Children (NCT01240746) | Sanofi Pasteur, a Sanofi Company | 2010-11-01 |
| Effect of Oseltamivir on Cognitive Function in Subjects With Influenza (NCT01249833) | Trial Management Group Inc. | 2010-11-01 |
| Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza (NCT01227798) | University Health Network, Toronto | 2010-11-01 |
| 2010/2011 Trivalent Influenza Vaccination (NCT01304563) | The University of Hong Kong | 2010-11-01 |
| Swine Flu (Influenza A H1N1) Follow on Vaccine Study (NCT01239537) | University of Oxford | 2010-11-01 |
| A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age (NCT01258595) | Sanofi Pasteur, a Sanofi Company | 2010-11-01 |
| Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old (NCT01355172) | Adimmune Corporation | 2010-11-01 |
| Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children (NCT01196988) | GlaxoSmithKline | 2010-10-04 |
| Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM (NCT01190215) | GlaxoSmithKline | 2010-10-04 |
| Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A) (NCT01204671) | GlaxoSmithKline | 2010-10-04 |
| From Innovation to Solutions: Childhood Influenza Vaccination Planning (NCT01664793) | University of Pittsburgh | 2010-10-01 |
| A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older (NCT01222403) | Novartis Vaccines | 2010-10-01 |
| Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines (NCT01086566) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Two-site Intradermal Influenza Vaccination in Elderly (NCT01202552) | Queen Saovabha Memorial Institute | 2010-10-01 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults (NCT01196975) | GlaxoSmithKline | 2010-10-01 |
| Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study (NCT01271842) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-10-01 |
| Comparison of Flu Vaccine Doses in Children (NCT01164553) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea (NCT01215669) | Sanofi Pasteur, a Sanofi Company | 2010-10-01 |
| TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B Boost (NCT01235000) | British Columbia Centre for Disease Control | 2010-10-01 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children (NCT01198756) | GlaxoSmithKline | 2010-10-01 |
| Surveillance for Adverse Events Following Influenza Immunization (NCT01318876) | PHAC/CIHR Influenza Research Network | 2010-10-01 |
| Study of Quadrivalent Influenza Vaccine Among Adults (NCT01218646) | Sanofi Pasteur, a Sanofi Company | 2010-10-01 |
| Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly (NCT01232868) | Emory University | 2010-10-01 |
| A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza. (NCT01224795) | BioCryst Pharmaceuticals | 2010-10-01 |
| Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V (NCT01229397) | Crucell Holland BV | 2010-10-01 |
| Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers (NCT01229371) | Crucell Holland BV | 2010-10-01 |
| Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children (NCT01246999) | University of Rochester | 2010-10-01 |
| Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria (NCT01286285) | University Children's Hospital, Wuerzburg | 2010-10-01 |
| Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults (NCT01195038) | UMN Pharma Inc. | 2010-10-01 |
| Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children (NCT01195779) | GlaxoSmithKline | 2010-09-30 |